Caricamento...
Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma
Tyrosine kinase inhibitors sunitinib and pazopanib are used as first-line agents in the treatment of metastatic renal cell carcinoma. Treatment-related toxicities have been described with both these drugs. This report describes a patient with metastatic renal carcinoma who developed trismus while be...
Salvato in:
| Pubblicato in: | Indian J Urol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Medknow Publications & Media Pvt Ltd
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5264200/ https://ncbi.nlm.nih.gov/pubmed/28197036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-1591.194787 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|